Lifevantage Corporation (LFVN)
NASDAQ: LFVNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
LFVN stock chart
Technical analysisKey statistics
All statistics- Market cap
- $75.54M
- P/E (TTM)
- 15.00
- Forward P/E
- 15.52
- EPS (TTM)
- $0.40
- Dividend yield
- 3.08% ($0.185)
- Ex-dividend date
- Sep 1, 2026
- 52-week range
- 3.90 – 11.71
- Day range
- 5.97 – 6.16
- Volume / Avg
- 24.95K / 61.76K
- Beta
- —
- Shares outstanding
- 12.59M
- Next earnings
- Nov 3, 2026
52-week range
LFVN stock today
On Oct 7, LFVN ended the session at $6.00, shedding $0.04 (0.66%), versus the S&P 500's 0.22% decline. Trading was light, with 24.95K shares changing hands, about 40% of the average daily volume. At this level, LFVN sits in the middle of its 52-week range of $3.90 to $11.71: 48.8% below the high, set on Jun 2, 2026 and 53.8% above the low.
LFVN is down 2.6% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 35.1%. Lifevantage trades at 15.0x its trailing twelve-month earnings per share of $0.40. Its forward P/E of 15.5x is higher than the trailing multiple, which means analysts expect earnings to decline over the next year. Lifevantage's next earnings report is expected on Nov 3, 2026.
Lifevantage pays an annual dividend of $0.185 per share, a 3.08% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Lifevantage
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Earnings
Earnings history- Next report
- Nov 3, 2026
- EPS estimate
- $0.03
Dividends
Dividend history- Annual dividend
- $0.185
- Dividend yield
- 3.08%
- Last payment
- $0.05
- Ex-dividend date
- Sep 1, 2026
Lifevantage peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ONCYOncolytics Biotech Inc. | 0.5958 | -0.37% | $75.97M | vs LFVN |
| RFLRafael Holdings Inc. Class B | 1.48 | -0.67% | $76.96M | vs LFVN |
| INCRIntercure Ltd. | 5.13 | -3.57% | $76.97M | vs LFVN |
| PDSBPDS Biotechnology Corporation | 1.07 | +1.91% | $77.19M | vs LFVN |
| NTHINeOnc Technologies Holdings Inc. | 2.71 | -9.36% | $78.06M | vs LFVN |
| HRTXHeron Therapeutics Inc. | 0.3843 | +15.86% | $72.96M | vs LFVN |
| GANXGain Therapeutics Inc. | 1.67 | 0.00% | $72.88M | vs LFVN |
| MAIAMAIA Biotechnology Inc. | 1.18 | -0.84% | $72.86M | vs LFVN |
Indexes, lists and sector
Appears in lists
Lifevantage stock FAQ
What is Lifevantage's stock price today?
LFVN last traded at $6.00 as of Oct 7, 4:00 PM EDT, down 0.66% on the day. Prices are delayed at least 15 minutes.
Does Lifevantage pay a dividend?
Yes. Lifevantage pays $0.185 per share annually, a 3.08% yield. The most recent dividend of $0.05 had an ex-dividend date of Sep 1, 2026.
When is Lifevantage's next earnings date?
Lifevantage is expected to report earnings on Tuesday, November 3, 2026. Analysts expect EPS of $0.03.
What is LFVN's P/E ratio?
LFVN trades at a trailing P/E ratio of 15.00 and a forward P/E of 15.52.
Has LFVN ever split its stock?
Yes. The most recent LFVN stock split was a 1-for-7 split on Oct 19, 2015, one of 2 splits on record.
What is the LFVN 52-week high?
The 52-week high for LFVN is $11.71 and the 52-week low is $3.90. The stock is currently 48.8% below its high.